652 related articles for article (PubMed ID: 15074465)
1. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
Jin F; Balthasar JP
Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Crow AR; Song S; Siragam V; Lazarus AH
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
[TBL] [Abstract][Full Text] [Related]
4. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
Bazin R; Lemieux R; Tremblay T; St-Amour I
Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
[TBL] [Abstract][Full Text] [Related]
5. Harmful and beneficial antibodies in immune thrombocytopenic purpura.
Imbach PA
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):25-30. PubMed ID: 8033430
[TBL] [Abstract][Full Text] [Related]
6. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
7. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
Bierling P; Godeau B
Hum Immunol; 2005 Apr; 66(4):387-94. PubMed ID: 15866702
[TBL] [Abstract][Full Text] [Related]
9. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
[TBL] [Abstract][Full Text] [Related]
10. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
Mehta YS; Badakere SS
J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
[TBL] [Abstract][Full Text] [Related]
11. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
Andersson PO; Wadenvik H
Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
Lazarus AH; Freedman J; Semple JW
Transfus Sci; 1998 Sep; 19(3):289-94. PubMed ID: 10351141
[TBL] [Abstract][Full Text] [Related]
14. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Crow AR; Lazarus AH
Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
[TBL] [Abstract][Full Text] [Related]
15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
17. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
Gernsheimer T
Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
[TBL] [Abstract][Full Text] [Related]
18. Immune pathophysiology of autoimmune thrombocytopenic purpura.
Semple JW
Blood Rev; 2002 Mar; 16(1):9-12. PubMed ID: 11913985
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to refractory immune thrombocytopenic purpura.
Bussel JB
Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
